glp-1 and pain its derived peptides mediate relief through direct TRPV1 inhibition without affecting thermoregulation Full article: GLP-1 agonists: a

However, symptoms that resemble low blood sugar can still occur, especially early in treatment or when nutrition is inconsistent

GLP-1 is the most well-known and extensively studied member of the glucagon-like peptide family

Serum copper monitoring (target range 70-150 g/dL) and ceruloplasmin (20-35 mg/dL) every 8-12 weeks provides objective safety data for patients on GHK-Cu protocols lasting longer than 30 days [5]

Gastrointestinal Side Effects The most common side effects of GLP-1 medications are gastrointestinal, including nausea, diarrhea, vomiting, constipation, and abdominal discomfort

Medicines in Development